Jianxun Qi | Biological Networks | Best Researcher Award

Dr. Jianxun Qi | Biological Networks | Best Researcher Award

Institute of Microbiology, Chinese Academy of Sciences | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianxun Qi laid a strong academic foundation in microbiology and virology, which paved the way for his remarkable contributions to structural biology and protein chemistry. His early focus was on understanding virus–host interactions, a field that would later define his scientific career and global recognition.

Professional Endeavors

Currently serving as a Professor at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS), Dr. Qi has established himself as a leading scientist in viral pathogenesis and structural virology. In 2021, he was selected as a leading talent in science and technology innovation under China’s prestigious “Ten Thousand Talent Program.” His professional trajectory reflects dedication to advancing viral immunology and translational research with broad societal impact.

Contributions and Research Focus

Dr. Qi’s work centers on deciphering the structural mechanisms of virus–receptor interactions, shedding light on the molecular dynamics of pathogens such as Influenza virus, Coronaviruses, Ebola virus, Thogotovirus, ASFV, Coxsackievirus A10, and SFTSV. Through high-impact publications in Science, Nature, Cell, EMBO, PNAS, and Nature Communications, he has provided pivotal insights into viral entry, immune evasion, and vaccine design. Recent studies extend his expertise to epitope-based vaccine development and broad-spectrum antiviral engineering, offering innovative approaches to combat emerging infectious diseases.

Impact and Influence

With over 19,000 citations and an H-index of 64, Dr. Qi’s research has had a profound influence on the global scientific community. His findings have shaped understanding of pandemic threats, including MERS-CoV, SARS-CoV-2, and Ebola virus, directly informing vaccine strategies and therapeutic interventions. His recognition as a Highly Cited Researcher (2021–2024) and inclusion in Stanford University and Elsevier’s World’s Top 2% Scientists List underscore his international impact.

Academic Citations and Recognition

Dr. Qi’s groundbreaking studies—such as structural revelations on Influenza H7N9 (Science, 2013), MERS-CoV (Nature, 2013), and SARS-CoV-2 (Cell, 2020, 2022)—are extensively cited worldwide. His pioneering discoveries have garnered major honors, including the First Prize of the Beijing Science and Technology Award (2011) and the First Prize of the Chinese Preventive Medicine Association Science and Technology Award (2017).

Legacy and Future Contributions

Dr. Qi’s legacy lies in bridging fundamental virology with translational medicine, guiding the development of next-generation vaccines and antivirals. His continued exploration of viral mechanisms, coupled with collaborative innovations such as epitope vaccines and monoclonal antibody studies, positions him to contribute further to global preparedness against pandemics. Looking ahead, his research promises to expand the frontiers of viral immunology and structural vaccinology.

Conclusion

Dr. Jianxun Qi exemplifies scientific excellence through his persistent pursuit of knowledge, impactful research, and leadership in microbiology. His influential work on virus–host interactions and vaccine innovation has not only advanced academic discourse but also delivered tangible benefits to public health. As he continues to push boundaries in virology and immunology, his contributions will remain a cornerstone for future breakthroughs in infectious disease prevention and control.

Notable Publications

"T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots

"Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2

  • Journal: Hlife
  • Citation: 5
  • Year: 2025

"Structural basis of DNA replication fidelity of the Mpox virus

"Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2

"Molecular mechanism of potently neutralizing human monoclonal antibodies against severe fever with thrombocytopenia virus infection

 

June Round | Biological Networks | Best Researcher Award 

Dr. June Round | Biological Networks | Best Researcher Award 

University of Utah | United States

Author Profiles

Scopus

Google Scholar

Early Academic Pursuits

Dr. June Round’s academic journey reflects a foundation of dedication and scholarly excellence. Beginning with a B.S. in Biology (Cum Laude) at California Lutheran University, she distinguished herself early through departmental honors and multiple scholarships. Her passion for molecular biology led to an M.S. from the University of the Pacific, followed by a D.Phil. in Microbiology, Immunology, and Molecular Genetics at UCLA, supported by highly competitive fellowships. Her formative postdoctoral training at the California Institute of Technology under Sarkis K. Mazmanian provided a strong platform to explore the intricate interplay between microbiota and host immunity, setting the stage for her pioneering career.

Professional Endeavors

Currently serving as a Professor at the University of Utah, Dr. Round has held numerous leadership roles including Director of the Mountain West Microbiota Alliance (MoWMA) and Co-Director of the Microbiota and GI Immunology Consortia (MAGIC). She has chaired multiple search committees, overseen postdoctoral studies, and contributed extensively to university-level, college-level, and departmental governance. Her sustained involvement in NIH study sections, national symposia, and scientific advisory boards underscores her standing as a leader in immunology and microbial pathogenesis.

Contributions and Research Focus

Dr. Round’s research focuses on microbiota–immune system interactions, particularly their role in regulating immune tolerance and driving inflammatory diseases. Her laboratory has produced high-impact work elucidating mechanisms by which commensal microbes shape host immunity, contributing to transformative understanding in immunology, microbiology, and gastrointestinal health. Her investigations into toll-like receptors, dysbiosis, and immune regulation have provided new frameworks for therapeutic exploration in autoimmune and inflammatory disorders.

Impact and Influence

The significance of Dr. Round’s research is reflected in her numerous prestigious awards, including the NIH Innovator Award, Packard Fellowship, Pew Scholar Award, Burroughs Wellcome Investigator in Pathogenesis, and the W.M. Keck Research Award. These honors not only recognize her innovative contributions but also demonstrate her influence in shaping the field. She has trained and mentored a generation of young scientists, many of whom now serve as professors, researchers, and clinicians in leading institutions worldwide—an enduring testament to her academic leadership.

Academic Citations and Recognition

Dr. Round’s scholarship has been widely published in top-tier journals including Cell, Nature Reviews Immunology, Science Immunology, and Annual Review of Microbiology. Her reviews and original research articles are highly cited, frequently shaping discourse in immunology and microbiome research. Her contributions extend beyond publications through book chapters and invited conference proceedings, amplifying her thought leadership in the global scientific community.

Legacy and Future Contributions

Dr. Round’s legacy lies in bridging microbiology and immunology, redefining the microbiota’s role in human health and disease. Through her pioneering studies, administrative leadership, and mentorship, she has cultivated a scientific ecosystem that will continue to grow. Moving forward, her leadership in major microbiome initiatives and consortia is poised to advance translational breakthroughs, from novel therapeutics for autoimmune disease to deeper insights into the human–microbe interface.

Conclusion

Dr. June Round’s career reflects the hallmarks of an exceptional researcher: rigorous scholarship, innovative vision, academic leadership, and transformative mentorship. Her pioneering contributions to microbiome and immune system research have reshaped fundamental scientific understanding while fostering future leaders in biomedical science. With her remarkable impact, both in the laboratory and across academic institutions, Dr. Round stands as an exemplary candidate for the Best Researcher Award.

Notable Publications

"Neonatal fungi promote lifelong metabolic health through macrophage-dependent β cell development

  • Author: JH Hill, R Bell, L Barrios, H Baird, K Ost, M Greenewood, JK Monts
  • Journal: Science
  • Year: 2025

"The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients

  • Author: DA Byrd, V Damerell, MF Gomez Morales, SR Hogue, T Lin, J Ose
  • Journal: International Journal of Cancer
  • Year: 2025

"A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy

  • Author: WW Tang, B Battistone, KM Bauer, AM Weis, C Barba, MZH Fadlullah
  • Journal: Cell reports
  • Year: 2025

"Primary tumor microbiomes predict distant metastasis of colorectal cancer

  • Author: B Parajuli, V Midya, R Kiddle, N De Jager, S Eggers, D Spakowicz
  • Journal: Cell reports
  • Year: 2025

"Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals

  • Author: TR Chiaro, M Greenewood, KM Bauer, KS Ost, E Stephen-Victor
  • Journal: bioRxiv
  • Year: 2025